Literature DB >> 15663920

Erectile dysfunction: interrelationship with the metabolic syndrome.

Glenn Matfin1, Ali Jawa, Vivian A Fonseca.   

Abstract

Erectile dysfunction (ED) is more commonly seen in men with various components of the metabolic syndrome (a constellation of various cardiovascular and diabetes risk factors). ED can be considered as a risk marker of the metabolic syndrome and its associated conditions. The patient with ED should be thoroughly evaluated for coexisting vascular disease. Any cardiovascular risk factors should be modified or treated (ie, smoking, diabetes, hypertension, and hyperlipidemia). Endothelial dysfunction is a major unifying etiology for many of the aspects of the metabolic syndrome, especially diabetes and cardiovascular disease. It also plays a major role in ED. The multifactorial etiology of ED, especially in patients with the metabolic syndrome, increases the complexity of managing this problem so clinicians need to be aware of the underlying pathophysiology to ensure the best possible outcomes in management.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15663920     DOI: 10.1007/s11892-005-0070-8

Source DB:  PubMed          Journal:  Curr Diab Rep        ISSN: 1534-4827            Impact factor:   4.810


  51 in total

1.  Insulin resistance, ADMA levels, and cardiovascular disease.

Authors:  David T Nash
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

2.  American Association of Clinical Endocrinologists medical guidelines for clinical practice for the evaluation and treatment of male sexual dysfunction: a couple's problem--2003 update.

Authors:  Andre T Guay; Richard F Spark; Sudhir Bansal; Glenn R Cunningham; Neil F Goodman; Howard R Nankin; Steven M Petak; Jesus B Perez
Journal:  Endocr Pract       Date:  2003 Jan-Feb       Impact factor: 3.443

3.  The efficacy of sildenafil citrate (Viagra) in clinical populations: an update.

Authors:  Culley C Carson; Arthur L Burnett; Laurence A Levine; Ajay Nehra
Journal:  Urology       Date:  2002-09       Impact factor: 2.649

4.  Sexual function in men with diabetes type 2: association with glycemic control.

Authors:  J H Romeo; A D Seftel; Z T Madhun; D C Aron
Journal:  J Urol       Date:  2000-03       Impact factor: 7.450

5.  Acute type 5 phosphodiesterase inhibition with sildenafil enhances flow-mediated vasodilation in patients with chronic heart failure.

Authors:  S D Katz; K Balidemaj; S Homma; H Wu; J Wang; S Maybaum
Journal:  J Am Coll Cardiol       Date:  2000-09       Impact factor: 24.094

6.  Impairment of corpus cavernosal smooth muscle relaxation by glycosylated human haemoglobin.

Authors:  J J Cartledge; I Eardley; J F Morrison
Journal:  BJU Int       Date:  2000-04       Impact factor: 5.588

7.  Age-related increase in an advanced glycation end product in penile tissue.

Authors:  D B Jiaan; A D Seftel; J Fogarty; N Hampel; W Cruz; J Pomerantz; M Zuik; V M Monnier
Journal:  World J Urol       Date:  1995       Impact factor: 4.226

8.  Effect of long-term passive smoking on erectile function and penile nitric oxide synthase in the rat.

Authors:  Y Xie; H Garban; C Ng; J Rajfer; N F Gonzalez-Cadavid
Journal:  J Urol       Date:  1997-03       Impact factor: 7.450

Review 9.  Etiology and treatment of erectile failure in diabetes mellitus.

Authors:  Donald Richardson; Aaron Vinik
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

10.  Improvement in erectile function in men with organic erectile dysfunction by correction of elevated cholesterol levels: a clinical observation.

Authors:  Erin A Saltzman; Andre T Guay; Jerilynn Jacobson
Journal:  J Urol       Date:  2004-07       Impact factor: 7.450

View more
  4 in total

Review 1.  [Metabolic syndrome and erectile dysfunction. Epidemiologic associations and pathogenetic links].

Authors:  A Wirth; M Manning; H Büttner
Journal:  Urologe A       Date:  2007-03       Impact factor: 0.639

2.  Reversal of voltage-dependent erectile responses in the Zucker obese-diabetic rat by rosuvastatin-altered RhoA/Rho-kinase signaling.

Authors:  Christopher J Wingard; Fatiha Moukdar; Raju Y Prasad; Brook L Cathey; Lois Wilkinson
Journal:  J Sex Med       Date:  2009-03       Impact factor: 3.802

3.  The impact of poor glycaemic control on the prevalence of erectile dysfunction in men with type 2 diabetes mellitus: a systematic review.

Authors:  Turki A Binmoammar; Sondus Hassounah; Saad Alsaad; Salman Rawaf; Azeem Majeed
Journal:  JRSM Open       Date:  2016-02-12

4.  Markers of erectile dysfunction.

Authors:  Kelvin P Davies; Arnold Melman
Journal:  Indian J Urol       Date:  2008-07
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.